Inferior Vena Cava (IVC) Filter Market, By Product (Permanent IVC Filter and Retrievable IVC Filter), By Application (Treatment Venous Thromboembolism (VTE), and Prevent Pulmonary Embolism (PE)), By End User (Ambulatory Surgical Centers (ASCs) and Hospitals), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Inferior Vena Cava (IVC) Filter Market was valued at US$ 865.8 million in 2024 and is projected to grow at a CAGR of 10.1% to reach US$ 2076.1 million by 2034.

The inferior vena cava (IVC) filters are small cone-shaped devices inserted in the inferior vena cava just below the kidney and then into the lungs. The inferior vena cava (IVC) is a large vein that sends deoxygenated blood from the lower and middle-level body into the heart's right atrium. This device is inserted permanently or temporarily based on the patient. The lack of them causes embolism, which blocks the pulmonary artery, and they have been gaining over the years.

The filter traps the blood clots in place until the body dissolves them. The IVCF process is typically painless and fast. The market is currently expanding as a result of patients who are at a higher risk of blood clots using IVC filters more frequently.

Good market trends are being driven by the increased global preference for minimally invasive surgical procedures, which is driving up demand for IVC filters. The increasing prevalence of occurrences of deep vein thrombosis (DVT) and venous thromboembolism (VTE), as well as increased public awareness of these illnesses, are driving the market's expansion

Inferior Vena Cava Filters Market faces constraints despite its growth trajectory. Healthcare professionals have carefully adopted this treatment due to concerns about its long-term safety and effectiveness, including filter migration, breakage, and thrombosis.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Inferior Vena Cava (IVC) Filter System Key Drivers:

Technological Developments in IVC Filters:

• Inferior vena cava (IVC) filter technology is being quickly advanced by several companies to increase product efficacy and safety. These procedures offer advantages such as reduced risk, shorter hospital stays, faster recovery times, and improved patient comfort. The guidance and facilitation of image-guided therapies, including vascular interventions, ablations, and image-guided biopsies, are greatly dependent on inferior vena cava (IVC) filters. Technological advancements in filter design and materials assist in enhancing biocompatibility and reducing the risk of adverse reactions and long-term complications

Increasing consumer knowledge of disease risks and effects:

• The general public and healthcare professionals are growing more aware of the risks and consequences of PE and DVT, which leads to increased demand for IVC filters. Agencies from various countries are promoting the use of IVC filters by educating the public, launching campaigns, and developing educational programs that center on preventing venous thromboembolism. Additionally, early diagnosis allows medical professionals to identify patients who can benefit from IVC filter implantation.

 Inferior Vena Cava (IVC) Filter System Market Restrains:

 Alternatives and Medical Therapies:

• Acceptance of inferior vena cava filters may be impacted by the availability of alternate methods for preventing VTE as well as medical treatments. Anticoagulant therapy prevents new clot formation and lets the patient's natural fibrinolytic processes break up any existing clot. Guidelines for the best administration of anticoagulant treatment in patients with VTE have been created.

   High cost of procedures:

• The market growth is impeded by the higher costs associated with treating inferior vena cava. The inferior vena cava filter market is thought to be restricted by the lack of awareness of IVC treatment among rural people in developing countries.

  Inferior Vena Cava (IVC) Filter System Market Opportunities:

• Opportunities in the industry are the Inferior Vena Cava (IVC) Filter market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on global market trends. To provide the overview of the inferior vena cava filter market with detailed market segmentation by product, material, application, and end user. The inferior vena cava market is expected to witness high growth during the forecast period. The report provides statistics on the market status of the leading player in the inferior vena cava filter market.

The inferior Vena Cava (IVC) Filter System Market is segmented based on product, application, end-user, and region.

Product Insights:

• Permanent IVC Filter: permanent IVC filters, which are designed to remain in place indefinitely, and retrievable IVC filters, which can be removed as soon as it is medically advisable. People who can’t take blood-thinning medications for health reasons usually get a permanent filter.
• Retrievable IVC Filter: The retrievable IVC filter represented the largest segment. Medical devices called retrievable IVC filters are designed to be temporarily implanted in patients who are at a high risk of pulmonary embolism. When the patient's condition improves or the risk of clot migration is reduced, they can be removed. An interventional radiologist typically performs the non-invasive retrievable IVC filter placement method. The market is growing as a result of the increasing use of retrievable IVC filters, which give healthcare providers additional therapy options.

 Application insights:

• Treatment Venous Thromboembolism (VTE): IVC filters are inserted into the inferior vena cava, which carries deoxygenated blood from the lower body to the heart, as part of the treatment for venous thromboembolism (VTE). This prevents blood clots from migrating to the lungs. They help lower the body's chance of suffering a pulmonary embolism and any related effects. In patients who are at high risk, they also offer an extra degree of protection against blood clot migration. Thus, improved patient outcomes and improved overall security are offered by VTE treatment.
• Prevent Pulmonary Embolism (PE): A blockage caused by a blood clot in the lung is known as a pulmonary embolism (PE). The lungs' oxygen and blood flow are affected by this. Medical emergency care involves PEs. We must receive a diagnosis and therapy right now. One of the most common heart and blood vessel diseases in the world is pulmonary embolism. It ranks third after heart attack and stroke.

    By End User:

• Ambulatory Surgical Centers (ASCs): It is modern medical facilities have a special focus on surgical procedures for outpatients. ASC services do not exceed 24 hours in duration. When choosing to have surgery at an ASC, patients arrive on the day of the procedure, have the treatment in a fully equipped operating room, and recover under the supervision of highly qualified nurses—all without being admitted to the hospital.
• Hospitals: IVC filters are primarily used by hospitals for patients with medical disorders, including those who are at high risk of venous thromboembolism (VTE), which gives them more effective treatment. IVC filters are frequently used in hospitals by patients having surgery, trauma or critical care, patients who are at risk of deep vein thrombosis (DVT), and pulmonary embolism (PE).

Regional Insights:

Inferior Vena Cava (IVC) Filter System Market Regional Insights

• North America the market’s growth will originate from North America during the forecast period. During the forecast period, the growth of the inferior vena cava filters market in North America will be assisted by increasing demand for IVCF placement procedures.
•  Asia Pacific this regional market had a predominant share in the global market in the forecast period. Factors such as an increase in the presence of a large patient pool population, and increased healthcare expenditure, developing facilities are expected to drive the market growth.
• The European is the second largest regional market and is estimated to witness a healthy CAGR during the forecast period. An increase in the PE incidence and rising population in this region will likely improve the market growth.
•  Latin America During the forecast period, it is anticipated to increase steadily. The growth component includes IVC filter research projects and increasing healthcare costs.
• Middle East & Africa Key Players: The global market share is smaller. The adoption of advanced inferior cava vena filters and innovative educational approaches are driving the market share's strengthening and will contribute significantly to the projected expansion of IVC filter treatment.

Report Scope:

Attribute	Details
Market Size 2024	US$ 865.8 million
Projected Market Size 2034	US$ 2076.1 million
CAGR Growth Rate	10.1%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Type - Permanent IVC Filter and Retrievable IVC Filter By Application - Treatment Venous Thromboembolism (VTE), and Prevent Pulmonary Embolism (PE) By End User - Ambulatory Surgical Centres (ASCs) and Hospitals
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report Coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For this study segmented the Inferior Vena Cava (IVC) Filter System Market report based on type, application, end users and region:

Inferior Vena Cava (IVC) Filter System Market, By Type:

• Permanent IVC Filter
• Retrievable IVC Filter

Inferior Vena Cava (IVC) Filter System Market, By Application:

• Treatment Venous Thromboembolism (VTE)

• Prevent Pulmonary Embolism (PE))

Inferior Vena Cava (IVC) Filter System Market, By End User

• Ambulatory Surgical Centers (ASCs)
• Hospitals

Inferior Vena Cava (IVC) Filter System Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Inferior Vena Cava (IVC) Filter System Services Market  Include Braun Melsungen AG, Accellent, Inc., Fukuda Denshi Co., Ltd., Biosensors International Group, Argon Medical Devices Ltd., Baxter International, Inc., Boston Scientific Corporation, Cardinal Health, Inc., Abbott Laboratories, Volcano Corporation.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

• In February 2023, Cook Medical received FDA approval for its Celect Vena Cava Filter, a new generation of retrievable IVC filter. The Celect Vena Cava Filter is designed to be more flexible and easier to insert than previous generations of filters, and it also has a retrieval rate of over 90%.
• In May 2022, Argon Medical announced a partnership agreement with Terumo India, a global leader in medical technology, to make their products available in India and provide end-to-end solutions for interventional radiology, vascular surgery, interventional cardiology, and clinical oncology.

• Braun Melsungen AG *
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Accellent, Inc.
• Fukuda Denshi Co., Ltd.
• Biosensors International Group
• Argon Medical Devices Ltd.
• Baxter International, Inc.
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Abbott Laboratories
• Volcano Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Research Objective and Assumption

• Preface
• Research Objectives
• Study Scope
• Years Considered for the study
• Assumptions
• Abbreviations

Research Methodology

• Research data
• Primary Data
  • Primary Interviews
  • Primary Breakdown
  • Key data from Primary Products
  • Key Thickness Insights
• Secondary Data
  • Major Secondary Products
  • Secondary Products
• Market Estimation
• Top-Down Approach
  • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
• Bottom-Up Approach
  • Approach for estimating market share by Bottom-up Analysis (Demand Side)
• Market Breakdown and Data Triangulation
• Research Assumptions

Market Preview

• Executive Summary
• Key Findings—Global Outlook for medical carts Strategies
  • Key Questions this Study will Answer
  • Market Snippet, By Product
  • Market Snippet, By Application
  • Market Snippet, By END USER
  • Market Snippet, By Region
• Opportunity Map Analysis
• Executive Summary—3 Big Predictions

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restrains
  • Market Opportunities
  • Market Trends
• DR Impact Analysis
• PEST Analysis
• Porter’s Five Forces Analysis
• Opportunity Orbit
• Market Investment Feasibility Index
• Macroeconomic Factor Analysis

Market Segmentation, By Product, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Permanent IVC Filter
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Retrievable IVC Filter
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Application, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Treatment Venous Thromboembolism (VTE)
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Prevent Pulmonary Embolism (PE)
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By END USER, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Ambulatory Surgical Centers (ASCs) 
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Hospitals
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Global Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By END USER, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By END USER, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • UK
    • France
    • Germany
    • Russia
    • Italy
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By END USER, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Latin America
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By END USER, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By END USER, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• GCC
• Israel
• South Africa
• Rest of Middle East

Competitive Landscape

• Heat Map Analysis
• Market Presence and Specificity Analysis

Company Profiles

• Braun Melsungen AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Accellent, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Fukuda Denshi Co., Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Biosensors International Group
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Argon Medical Devices Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Baxter International, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Boston Scientific Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Cardinal Health, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Abbott Laboratories
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Volcano Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

The Last Word

• Future Impact
• About Us
• Contact